bpc-157 + tb-500 nasal spray intranasal study Inside the ion-enhanced, easy-to-administer BPC-157 /TB-500 TB-500 Nasal Spray | Research

The Committee's recommendations are advisory in nature, and the FDA retains final authority regarding whether any substance is ultimately included on the FDA's 503A Bulks List

Blood sugar control: Tirzepatide helps lower blood sugar levels by stimulating the release of insulin, which helps move glucose into cells for energy, and by reducing the production of glucose in the liver

None of the above peptides have gone through one

Each vial contains 10mg of BPC-157 and 10mg of TB-500 supplied as a lyophilized research peptide blend

Supplies Needed Plan based on a 48 week daily protocol (standard approach at ~1 mg/day maintenance)